
2023
32
The company’s dividend policy is that the company
does not expect to pay any dividend in the short
to medium term as the company intends to use
its profit for both organic and inorganic growth
initiatives as well as product and technology
innovation. The company will in the future
continuously evaluate its capital allocation and
will prioritize organic growth investments and
acquisitions over dividends if the company expects
that this will generate an attractive return on
capital.
At the Annual General Meeting on April 28th, 2023,
the Board was granted the following authorities:
o Authorization to increase the share capital in
one or more rounds by up to NOK 17 152,305.
The authorization covers contribution in kind
and the right to incur specific obligations on
behalf of the Company and includes mergers.
There have not been issued any new shares
under this authorization. The authorization
is valid until the Company’s Annual General
Meeting in 2024, but not longer than June 30th,
2024.
o Authorization to acquire own shares with a
total nominal value up to NOK 85 761,15 which
is equivalent to 5 percent of the current share
capital. The maximum purchase price is NOK
50 and minimum NOK 1. As of December
31st, 2023, the authorization has been used to
purchase 3 076 249 shares for a total of TNOK
60 520. The authorization is valid until the
Company’s Annual General Meeting in 2024,
but not longer than June 30th, 2024.
EQUAL TREATMENT OF
SHAREHOLDERS
All shareholders shall be treated on an equal
basis unless there is a just and factual cause
for treating them differently. Each share in the
Company carries one vote, and all shares carry
equal rights, including the right to participate
in general meetings and the right to dividends.
Where the Board of Directors resolves to issue new
shares and deviate from existing shareholders’
pre-emptive rights pursuant to an authorization
granted to the Board of Directors, the stock
exchange announcement issued in connection with
the share issue shall also include a justification for
the deviation.
The Company’s transactions in treasury shares
shall be carried out through Oslo Stock Exchange’
trading platform at the prevailing trading price or
by making a public offer to all shareholders. All
transactions in treasury shares shall be publicly
disclosed in a stock exchange announcement.
There was a total of 239 transaction in treasury
shares in 2023 which was carried out by Carnegie
on behalf of the Company.
Transactions between the Company and its
shareholders, a shareholder’s parent company,
members of the Board of Directors, executive
management or closely associated persons to any
such party, that are deemed material under the
Norwegian Public Limited Liability Companies Act,
are subject to approval by the general meeting.
Furthermore, the Board of Directors is required
to arrange for an independent auditor’s valuation
of the transaction. When restructuring the Group
companies there was performed several transfers
of shares internally. The transactions were not
subject to approval by the general meeting as it
was defined as an intercompany transaction.
FREELY TRANSFERABLE SHARES
The shares of the Company are listed on the Oslo
Stock Exchange and are freely transferable and
there are no limitations on any party’s ability to
own or vote for the shares in the Company.
Deviation from the Code of Practice:
Sellers of the shares in Inprog AS and Coredination
AB has entered into a lock-up agreement for
shares purchased as part of the settlement. The
lock-up period for the sellers of Inprog AS was
valid until January 26th, 2024, and February 21st,
2024, while the lock-up period for the sellers of
Coredination AB is valid until July 7th 2024, August
7th 2024, and August 15th 2024.